Proteasome from cytokine-treated human cells shows stimulated BrAAP activity and depressed PGPH activity.

The branched chain amino acid-preferring (BrAAP) activity of multicatalytic proteinase complex isolated from human umbilical vein endothelial cells and treated with interferon-gamma was increased more than 2-fold, which was associated with a marked increase in LMP7 expression and decreased peptidylglutamyl peptide-hydrolyzing activity. Increases in BrAAP activity in supernatants from cells treated with interferon-gamma, tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, or lipopolysaccharide paralleled the increases in LMP7 expression. These findings are consistent with the conclusion that the increased BrAAP activity of LMP-containing multicatalytic proteinase complex results from incorporation of LMP7 or other LMP subunits.

[1]  M. Orłowski,et al.  Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues. , 1999, Biochemistry.

[2]  M. Orłowski,et al.  Reactions of [14C]-3,4-dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes). , 1997, Biochemistry.

[3]  Marian Orlowski,et al.  Bovine Spleen Multicatalytic Proteinase Complex (Proteasome) , 1997, The Journal of Biological Chemistry.

[4]  M. Orłowski,et al.  Differences in Catalytic Activities and Subunit Pattern of Multicatalytic Proteinase Complexes (Proteasomes) Isolated from Bovine Pituitary, Lung, and Liver , 1995, The Journal of Biological Chemistry.

[5]  M. Orłowski,et al.  Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes. , 1994, The Journal of biological chemistry.

[6]  K. Tanaka,et al.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.

[7]  E. Urcelay,et al.  Functional coupling of Na+/H+ and Na+/Ca2+ exchangers in the alpha 1-adrenoreceptor-mediated activation of hepatic metabolism. , 1994, The Journal of biological chemistry.

[8]  M Orlowski,et al.  Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. , 1993, Biochemistry.

[9]  M. Orłowski,et al.  The multicatalytic proteinase complex, a major extralysosomal proteolytic system. , 1990, Biochemistry.

[10]  M. Orłowski,et al.  Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. , 1989, Biochemistry.

[11]  M. Orłowski,et al.  Substrate-related potent inhibitors of brain metalloendopeptidase. , 1988, Biochemistry.

[12]  M. Orłowski,et al.  Substrate and inhibitor studies of thermolysin-like neutral metalloendopeptidase from kidney membrane fractions. Comparison with bacterial thermolysin. , 1986, Biochemistry.

[13]  M. Orłowski,et al.  Peptide-degrading enzymatic activities in GH3 cells and rat anterior pituitary homogenates. , 1984, Endocrinology.

[14]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.